|
|
||||||||||||||
|
||||||||||||||
|
Post Summit Strategy Session
The Oberoi, New Delhi November 11th, 2011 |
||||||
Co-Chairs:
Action agenda emerging from USAIC’s annual global summit Explore the implications for decision makers in India Discuss the agenda for the 2012 summit |
||||||
| US India BioPharma & Healthcare Summit 2011 Hyatt Regency, Cambridge 575 Memorial Drive, Cambridge, MA 02139, USA Thursday, June 23, 2011 |
||||||
Program Summary Summit Emcee - Dr. Bill Chin, Executive Dean for Research, Harvard Medical School Opening remarks: Karun Rishi, President-USA-India Chamber of Commerce Panel Discussion: Drug Discovery and Collaborative Research: Increasing the odds of success Panelists: Dr. Martin Fitchet, Chief Operating Officer, Johnson & Johnson Pharma R&D; Dr. Ivan Gergel, Executive Vice President R&D, Endo Pharmaceuticals; Dr. John Leonard, Senior Vice President- Pharmaceuticals R&D, Abbott; Sri Mosur, CEO, Global Drug Discovery & Development, Jubilant Life Sciences; Dr. Peter Mueller, Executive Vice President- Global R&D, Vertex Pharmaceuticals Moderator: Dr. Bill Chin, Executive Dean for Research, Harvard Medical School Panel Discussion: "Show me the Money": Funding innovation, investment opportunities and cross border M&A trends in the BioPharma & Healthcare Panelists: Hari Bhartia, Co-Chairman & Managing Director, Jubilant Life Sciences; Dr. Ansbert Gadicke, Founder & Managing Director, MPM Capital; Robert King, Senior Partner, Global Healthcare Group, Goldman Sachs; Joel Marcus, Chairman & CEO, Alexandria Real Estate Equities; K.V. Subramaniam, President & CEO, Reliance Life Sciences Moderator: Jeff Elton, Founder & CEO, KEW Group Panel Discussion: Industry-Academia Partnerships: Can they be the engine of a new wave of innovation? Panelists: Dr. Harris Berman, Dean ad interim, Tufts University School of Medicine; Dr. M.K. Bhan, Secretary, Department of Biotechnology, Govt. of India; Dr. Vijay Chandru, Chairman & CEO, Strand Life Sciences; Julius Knowles, Head, Platforms, Strategic Alliances, NIBR (Novartis); Dr. Lansing Taylor, Director, Drug Discovery Institute, University of Pittsburg Moderator: Dr. Barry Bloom, Distinguished Service Professor, Harvard School of Public Health Panel Discussion: Diabetes - Science, Research trends and Market Opportunities Panelists: Dr. Martin Fitchet, Chief Operating Officer, Johnson & Johnson Pharma R&D; Dr. William Mezzanotte, Vice President- Global Products Leadership, AstraZeneca; Dr. Steven Shoelson, Professor of Medicine, Joslin/Harvard Medical School; Kiran Mazumdar-Shaw, Chairman & Managing Director, Biocon; Dr. Suri Venkatachalam, Founder & CEO, Connexios Life Sciences Moderator: Dr. Paul Strumph, Vice President-Therapeutic Strategy Lead, Quintiles Panel Discussion: Moving the needle on Drug Development, Clinical Research & other Healthcare opportunities Panelists: Dr. Nora Dyer, Head of Search & Evaluation, Novartis Pharmaceuticals; Dr. Nirmal Ganguly, Chairman JIPMER, & ex-Director General ICMR; Krishna Kanumuri, Chief Executive Officer, Sai Advantium; Sanjay Mittal, Director- Research & Clinical Cardiology, Medanta -The Medicity; Debasish Roychowdhury, Head of Global Oncology, Sanofi Moderator: Dr. Gunther Winkler, Senior Vice President, Biogen Idec Presentation of USA-India Chamber of Commerce commissioned annual Position Paper by Bart Janssens, Partner, The Boston Consulting Group Strategy Sessions Co-Chairs Richard D. Connell, PhD, Vice President and Head of Asia Research, Pfizer Sandeep Gupta, PhD, Senior Vice President of Drug Discovery & Early Development, Endo Pharmaceuticals Sri Mosur, President & CEO, Global Drug Discovery & Development, Jubilant Life Sciences Isaac T. Kohlberg, Senior Associate Provost & Chief Technology Development Officer, Harvard Sridaran Natesan, PhD, Scientific Site Head - R&D & Head External Innovation & Partnering- NE, Sanofi Cocktails and Networking Reception |
||||||
 |
||||||
 |
||||||
 |
||||||
|
||||||
| US India BioPharma & Healthcare Summit 2010 Hyatt Regency, Cambridge 575 Memorial Drive, Cambridge, MA 02139, USA Thursday, May 6, 2010 |
||||||
Co-Chair Dr. Martin Mackay, President Global R&D Pfizer Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd Mervyn Turner, Chief Strategy Officer, Merck & Company Dr. Naresh Trehan, Chairman MediCity Program Summary Click here to view summit pictures Master of Ceremonies - Dr. Martin Mackay, President Global R&D Pfizer Opening remarks: Karun Rishi, President-USA-India Chamber of Commerce Panel Discussion: Industry-Academia Partnerships Panelists: Dr. Allen M Spiegel, Dean, Albert Einstein College of Medicine, Yeshiva University; Balu Balasubramanian, PhD, Managing Director, BMS-Biocon R&D Center; Dr. David Golan, Dean of Graduate Education, Harvard Medical School; Dr. Nirmal Ganguly, Chairman JIPMER, Ex-Director General ICMR; Kiran Mazumdar-Shaw, Chairman & Managing Director, Biocon Moderator: Dr. Barry R. Bloom Distinguished Service Professor, Harvard School of Public Health Panel Discussion - Funding innovation, investment opportunities and cross border M&A trends in US-India BioPharma & Healthcare Panelists: Joel Marcus, Chariman and CEO, Alexandria; K.V. Subramaniam, President & CEO, Reliance Life Sciences; Dr. Ansbert Gadicke, Founder & Managing Director, MPM Capital; Utkarsh Palnitkar, Executive Director, Centrum Capital Limited; Brian Atwood, Founding Partner, Versant Ventures Moderator: Jeff Elton, Founder & CEO, KEW Group Presentation by: Dr. Marc Cluzel, Executive Vice President & Global Head of R&D, Sanofi aventis - From Preferred Partner to Preferred Network Presentation by: Dr. Mervyn Turner, Chief Strategy Officer & Senior Vice President Emerging Markets R&D, Merck & Co. - How can India foster innovation in Health Care? Panel Discussion: Collaborative Research and Drug Discovery Panelists: Dr. David Lacey, Senior Vice President- Research, Amgen; Dr. Peter Mueller, Executive Vice President, Global R&D & CSO, Vertex Pharmaceuticals; Sri Mosur, Chief Executive Officer, Jubilant Biosys; Dr. Paul Stoffels, Global Head- R&D Pharma, Johnson & Johnson; Davinder Brar, Chairman, GVK Biosciences Moderator: Dr. Martin Mackay, President PharmaTherapeutics R&D, Pfizer Presentation by: Dr. Rod MacKenzie, Senior Vice President & Head of Worldwide Research, PharmaTherapeutics, Pfizer - Pfizer in India Panel Discussion: Drug Development, Clinical Research & Healthcare opportunities Panelists: Dr. Michael Rosenblatt, Executive Vice President & Chief Medical Officer, Merck & Co.; Dr. Sanjay Mittal, Director-Clinical Cardiology & Research, Medanta, The Medicity; Dr. Nirmal Ganguly, Chairman JIPMER, Ex-Director General ICMR; Dr. Paul Stoffels, Global Head- R&D Pharma, Johnson & Johnson; Dr. Robert Taber Vice Chancellor- Corporate & Venture Devp, Duke University Medical Moderator: Alka Goel, Associate Principal, McKinsey & Company Presentation of USA India Chamber of Commerce commissioned McKinsey & Company Position Paper. Ajay Dhankar and Vikas Bhadoria Closing Remarks - Dr. Gunther Winkler, Sr. Vice President, Biogen Idec Cocktails and Networking Reception |
||||||
Media Partners
| ||||||
| Pharmaceuticals & Healthcare Brainstorming Session with a group of 30 Lok Sabha and Rajya Sabha Members of Parliament, India, Constitution Club, New Delhi December 4, 2009 Chaired by Honorable Srikant Jena, Minister of State for Chemicals & Fertilizers Opening Remarks- Karun Rishi, President, USA-India Chamber of Commerce Moderated by- Prof. Barry Bloom, Past Dean, Harvard School of Public Health 
  
 |
||||||
| India Pharma Summit November 30, 2009 Grand Hyatt, Mumbai, India Organized by Department of Pharmaceuticals Government of India Click here for program details |
||||||
| 2009-10 Meetings & Roundtables by USA-India Chamber of Commerce | ||||||
|
||||||
| Business Roundtable and Post Summit follow up with Ashok Kumar Secretary to the Government of India, Department of Pharmaceuticals Monday, June 22, 2009 12:00 pm - 2:00 pm Location: Harvard Faculty Club, Cambridge, MA |
||||||
| Opening remarks Prof. Barry R. Bloom, Harvard School of Public Health Remarks Karun Rishi, President, USA-India Chamber of Commerce Q&A and Open Discussion Business Roundtable open to C level and senior executives from Healthcare, Pharma, Biotech, Medical Devices, Investment firms and Academia. |
||||||
| US India BioPharma & Healthcare Summit 2009 Hyatt Regency, Cambridge 575 Memorial Drive, Cambridge, MA 02139, USA Thursday, May 14, 2009 |
||||||
Co-Chair Dr. Martin Mackay, President Global R&D Pfizer Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd Dr. Naresh Trehan, Chairman MediCity Jeff Elton, Life Sciences Investor & Consultant Opening remarks: Karun Rishi, President-USA-India Chamber of Commerce Release of USA-India Chamber of Commerce commissioned McKinsey & Company Position Paper by Dr. Martin Mackay, President Global R&D Pfizer. Panel Discussion: Healthcare, Clinical Research and Industry-Academic Partnerships Panelists : Dr. Gerald Keusch, Associate Provost, BU School of Public Health, Dr. David Lacey, Senior Vice President & Head of Research, Amgen, Dr. Michael Rosenlatt, Dean Tufts University School of Medicine, Joe Smith, MD, PhD, Vice President-Emerging Technologies, Johnson & Johnson, Sridhar Mosur, Chief Executive Officer, Jubilant Biosys Moderator: Dr. William Chin, Vice President - Discovery Research & Clinical Investigation, Eli Lilly & Company Introduction by Manni Kanti Pudi, President, GVK BioSciences Keynote Address: Dr. Martin Mackay, President, Pfizer Global Research & Development Panel Discussion: Funding Innovation, Cross Border Investment and M&A Trends Panelists: K.V.Subramaniam, President & CEO, Reliance Life Sciences; Jeff Collins, Executive in Residence, Pappas Ventures; Jeffrey Elton, Life Sciences Investor & Consultant; George Bickerstaff, Managing Director, CRT Investment Banking; Shrikumar Suryanarayan, Director General, ABLE Moderator: Glen Giovanneti, Global Biotechnology Leader, Ernst & Young Introduction: Banashri Bose Harrison, Minister (Commerce), Embassy of India Keynote Address by Nobel Laureate Dr. Sidney Altman Presentation by Department of Pharmaceuticals, Govt of India. Paresh Johri, Deputy Secretary Panel Discussion: Drug discovery, Development and Collaborative Research Panelists: Robert Armstrong, PhD, Vice President, Global External R&D, Eli Lilly; Venkat Jasti, Chairman & CEO, Suven Life Sciences; Ismail Kola, PhD, Senior Vice President- Discovery Research & Chief Scientific Officer, Schering-Plough; CSN Murthy, Chief Executive Officer, Aurigene Discovery; Dr. John Thompson, Vice President, Strategic Research Alliances, Vertex Moderator: Ramesh Srinivasan, Principal, McKinsey and Company Introduction: Reid Leonard, PhD, Executive Director, External Research & Licensing, Merck & Co. Presentation of distinguished services award to Dr. Barry R. Bloom Introduction by Dr. Gerald Keusch, Associate Provost, BU School of Public Health Award Presentation by Dr. Martin Mackay and Karun Rishi Address by Dr. Barry R. Bloom, Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Department of Immunology and Infectious Diseases, Harvard School of Public Health Closing Remarks - James Mullen President & CEO, Biogen Idec Cocktails and Networking Reception |
||||||
Media Partners     |
||||||
| US India BioPharma & Healthcare Summit 2008 Hyatt Regency, Cambridge Friday, June 13, 2008 |
||||||
Master of Ceremonies: Hon. Andrew Maguire, PhD, Executive Director-GAVI
Opening remarks: Karun Rishi, President USA-India Chamber of Commerce Presentation of USA-India Chamber of Commerce commissioned McKinsey & Company Position Paper Panel Discussion: Drug Discovery, Collaborative Research and Strategic Alliances Panelists: Dr. William Chin, Vice President - Discovery Research, Eli Lilly Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences Dr. Peter Mueller, Exe. Vice President & CSO, Vertex Pharmaceuticals Barbara Yanni, Chief Licensing Officer, Merck & Co. Dr. Rashmi Barbhaiya, Co-Founder and CEO, Advinus Therapeutics Official Release of Position Paper and Keynote address by Honorable Kapil Sibal, Minister of Science & Technology and Earth Sciences, Government of India Networking and Tea Break Panel Discussion: Funding Innovation, Investment Opportunities, Cross Border M&A trends Panelists: Frederick Frank, Vice Chairman & Director, Lehman Brothers Dr. Helmut M. Schühsler, Managing Partner, TVM Capital Tom Andrews, Senior Vice President, Alexandria Real Estate Equities Sri Mosur, President & CEO, Jubilant Biosys Ltd. Dr. Jasmin Patel, Managing Director, Fidelity Capital Management (India) Keynote address by Dr. Surinder Singh, Drug Controller General of India Introduction: James Mullen, President & CEO, Biogen Idec and past Chairman, Biotechnology Industry Organization (BIO) Keynote address by Dr. Joshua Boger, President & CEO, Vertex Pharmaceuticals and Chairman, Biotechnology Industry Organization (BIO) Panel Discussion: Drug Development & Manufacturing, Clinical Research and In/Out Licensing Panelists: Dr. Mark Powell, Sr VP & Worldwide Head-Pharmaceutical Development, Bristol Myers & Squibb Gregg Alton, Senior Vice President, Gilead Sciences Dr. Gunther Winkler, Sr. Vice President, Biogen Idec Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd. Dr. Dianne Kikta, Vice President Global Clinical, Wyeth Dr. Sreeni Devidas, Vice President, GVK BioSciences Closing Remarks Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce Cocktails and Networking Reception |
||||||
|
Media Partners  |
||||||
| US India BioPharma & Healthcare Summit - 2007 Monday, May 7 Hotel Omni Parker House 60 School Street, Boston, MA 02108, USA |
||||||
2007 Summit Pictures
Welcome address: Karun Rishi, President, USA-India Chamber of Commerce Opening remarks: James C. Mullen, Chairman Biotechnology Industry Organization (BIO), CEO & President, Biogen Idec Release of USA-India Chamber of Commerce commissioned Ernst & Young Position Paper on Indian Biotech industry Panel Discussion: Discovery, Development, IP & Regulatory Issues Panelists: Dr. Alan Smith, Chief Scientific Officer, Genzyme Dr. Peter Mueller, Chief Scientific Officer, Vertex Pharmaceuticals Dr. Rashmi H.Barbhaiya, CEO and MD, Advinus Therapeutics Dr. Sridhar Mosur, Managing Director, Jubilant Chemsys Ltd Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd. Moderator: David C U'Prichard, PhD, Partner, Red Abbey Venture Partners and Care Capital Keynote Address: Dr.M.K.Bhan, Secretary-Govt of India, Dept of Biotechnology Introduction to Dr. MK Bhan by Joel Marcus, CEO of Alexandria Real Estate Equities Panel Discussion: Investment Opportunities, Cross Border Investments, M&A Trends in US-India Life Sciences industry Panelists: Dr. Helmut M. Schühsler, Managing Partner, TVM Capital Dr. David Gluckman, MD & Head of European Life Sciences, Lazard George Bickerstaff, Managing Director, CRT Capital Group Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd Dr. Stephen Knight, Managing Partner, Fidelity Biosciences Moderator: Utkarsh Palnitkar , Partner-Transaction Advisory Services, Industry Leader - Health Sciences, Ernst & Young Closing remarks: Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce Cocktails & Networking Reception Media Partners  |
||||||
The Deal's BRIC Symposium
April 12, 2007 Agenda & Registration Location: The Westin New York at Times Square USA-India Camber of Commerce is the Association Partner of BRIC Symposium. USAIC members save 15% off the The Deal's BRICs Symposium. M&A and Investment opportunities in key emerging economies continue to thrill and terrify US professionals. In this one-day symposium, an audience of bankers, strategic acquirers, private equity partners and other alternative investment will gather in New York to hear the strategies and perspective of the leading investors and dealmakers who are having significant success currently in Brazil, Russia, India and China (BRIC). |
||||||
India Healthcare Luncheon Business Roundtable
India Healthcare Luncheon Business Roundtable with Dr. Anbumani Ramadoss, Honorable Union Minister of Health, Government of India and Prof. N.K. Ganguly, Director General, Indian Council of Medical Research (ICMR). Opening remarks: Prof. Barry R. Bloom, Dean, Harvard School of Public Health Remarks: Karun Rishi, President, USA-India Chamber of Commerce Q&A and open discussion Date: Friday, March 30, 2007 Location: Harvard Faculty Club, Cambridge, MA
Event is complementary for members.   |
||||||
India Business Summit
Special focus on opportunities for US SME companies in India. The two day conference besides several keynotes will have sessions on IT, ITeS, Retail, Real Estate, Food Processing, Auto and Auto Components, Financing, Entrepreneurship, Policy, Market Access, Emerging sectors and Export opportunities. Senior policy makers and key executives from Walmart, Citigroup, Bank of America, SBA, Coca-Cola, Kelloggs, Tishman Spyer, Parsons, IBM, Hero Group, UPS, Bharti, General Motors, EXIM Bank, and Proctor & Gamble etc will participate in the panel discussions. Place: Maurya Sheraton Hotel, New Delhi, India Date: Jan 23-25, 2007 |
||||||
India Healthcare Business Roundtable
Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce Remarks by Prof K. Srinath Reddy, Professor and Head, Department of Cardiology, All India Institute of Medical Sciences (AIIMS) and President, Public Health Foundation of India Remarks by Prof. Barry R. Bloom, Dean, Harvard School of Public Health Q&A and open discussion Closing Remarks: Stephen Knight, Managing Partner, Fidelity Biosciences Date: Wednesday, December 6, 2006 Location: Downtown Harvard Club Boston, Massachusetts The discussion will focus on:
Prof Reddy was recently appointed President of the Public Health Foundation of India. Dr. Reddy Chairs numerous healthcare commissions and committees in India and internationally. Exciting things are happening in IndiaÂ’s healthcare sector. Industry, Academia, Research institutions and Investors in the US need to take a serious look at India opportunity. This roundtable is only for senior executives. Event is complementary for members. |
||||||
BUSINESS DEVELOPMENT MISSION TO INDIA
November 29 to December 5, 2006 USA-India Chamber of Commerce is pleased to support the Business Development Mission led by Amb. Franklin L. Lavin, Under Secretary for International Trade, U.S. Department of Commerce. This precedent-setting initiative, potentially involving the largest ever overseas delegation of its kind led by a U.S. Government official, will serve as the capstone of a year of successful activities conducted under the auspices of the U.S.-India Commercial Dialogue, honoring the commitment of President Bush and Indian Prime Minister Manmohan Singh to revitalize bilateral trade discussions. This is a great opportunity to get access to IndiaÂ’s high-level business, industry, and government representatives and opportunities to gain timely insights into the countryÂ’s trade and investment climate. We strongly recommend and encourage you participate and benefit from this important business mission to India. For details please visit India Mission |
||||||
The New York Society of Security Analysts in association with USA-India Chamber of Commerce presents ‘Investing in Asia’ conference.
Date: Thursday, September 28, 2006 Location: NYSSA, 1177 Avenue of the Americas, 2nd floor (between 45th and 46th Streets), New York, NY 10036 Photo ID required for access to the building. Credit: PD/CE/CPE = 1 Asia has become a crucial part of the global economy, boasting three of the ten largest economies—China, Japan, and India—and contributing more than 35% of world GDP. Investment has been booming in recent years, with Asia accounting for about 40% of net private capital flows into emerging markets. The region’s economy is now the fastest growing in the world, and contributes close to 50% of global growth. Aggregate GDP for Asia expanded by a robust 7.4% in 2005. This growth has been supported by a favorable external environment and continuing progress on domestic reform issues. Experts expect China and India to continue to be the fastest-growing countries in the region, with projected 2006 GDPs of 9.5% and 7.3%, respectively. Where are the next best investment opportunities in Asia? Hear from the senior executives of growing public companies from the region, and learn what leading experts have to say about AsiaÂ’s economic outlook. |
||||||
USA-India Chamber of Commerce presents Business Lunch Roundtable with David Bohigian, Assistant Secretary, International Trade Administration, U.S. Department of Commerce.
Program Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce Introduction: Nigel Thompson, Executive Director, Merck Business Roundtable with David Bohigian, Assistant Secretary, U.S. Department of Commerce Closing Remarks: Michael Fondo, Director, Fidelity Investments Date: Tuesday, May 2, 2006. Location: Fairmont Copley Plaza Hotel, Boston Assistant Secretary BohigianÂ’s Market Access and Compliance (MAC) division identifies and overcomes trade barriers, resolves trade policy issues, and ensures that our trading partners fully meet their obligations under our trade agreements. MAC ensures access to world markets for American companies. MAC focuses on issues such as: Intellectual Property and Piracy, Quotas, Standards, Customs, Transparency and Contract Sanctity, National Treatment and Good Governance. This roundtable is only for senior executives. Event is complementary for members. |
|
|||||
Annual International Business Forum and Networking Evening
Date: Tuesday, May 2, 2006. Location: One Financial Center, Boston, MA 02111 The Global Economic Outlook: Implications for International Business in the Year Ahead: Christopher Probyn, Chief International Economist, State Street Corporation Keynote speaker: David Bohigian, Assistant Secretary, US Department of Commerce Panel discussion: Assessing & Managing Risk in the Global Marketplace The business forum will kick off with a Global Economic Outlook seminar, which will include information on global market indicators and implications for international business in the year ahead. The forum will also include a session on Assessing and Managing Risk in the Global Marketplace, featuring panelists who will discuss techniques for assessing and mitigating various risks of doing business internationally: global security; political, economic and credit risk; intellectual property protection and commercial risks; and regulatory compliance. |
||||||
Interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India
Date: Tuesday, March 14, 2006 Location: Downtown Boston USA-India Chamber of Commerce presents an interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India, Washington DC. He is a senior diplomat and a key person responsible for trade and exim policy issues. He is also an expert on WTO issues. This will be the first briefing nationally discussing the trade agreements signed last week during President Bush's India visit. Agenda:
|
||||||
USA-India Chamber of Commerce and USIBC present an Executive Luncheon Business Roundtable with Satwant Reddy, Secretary to Government of India, Ministry of Chemicals. She is the top ranking official in the ministry. Her portfolio includes the regulation of all state-owned chemical companies, pharmaceuticals, and petrochemicals. Among other things, she is tasked responsibility for formulating India ’s data exclusivity and pharmaceutical price control policies Date: January 27, 2006 Location: Downtown Boston It is a member’s only event for senior executives. This event is complementary for our members. |
||||||
Jan 26, 2006 Dinner meeting with Ms. Satwant Reddy, Secretary to Government of India, Ministry of Chemicals & Petrochemicals and Prof. Josh Lerner, Jacob H. Schiff Professor of Investment Banking, Harvard Business School and author of the book: 'Innovation and Its Discontents’: How Our Broken Patent System is Endangering Innovation and Progress. Exclusively for members and sponsors. This roundtable is only for senior executives. Event is complementary for members. |
||||||
| © 2011 USA India Chamber of Commerce | Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us |